180 related articles for article (PubMed ID: 1285731)
1. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.
Eddy DM
J Clin Oncol; 1992 Apr; 10(4):657-70. PubMed ID: 1285731
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
Winer EP; Lindley C; Hardee M; Sawyer WT; Brunatti C; Borstelmann NA; Peters W
Psychooncology; 1999; 8(2):167-76. PubMed ID: 10335560
[TBL] [Abstract][Full Text] [Related]
3. Tandem autotransplantation for the treatment of metastatic breast cancer.
Broun ER; Sridhara R; Sledge GW; Loesch D; Kneebone PH; Hanna M; Hromas R; Cornetta K; Einhorn LH
J Clin Oncol; 1995 Aug; 13(8):2050-5. PubMed ID: 7636548
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
Smith GA; Henderson IC
Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
[No Abstract] [Full Text] [Related]
6. Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results.
Hillner BE; Smith TJ; Desch CE
JAMA; 1992 Apr; 267(15):2055-61. PubMed ID: 1552641
[TBL] [Abstract][Full Text] [Related]
7. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
Vredenburgh JJ; Coniglio D; Broadwater G; Jones RB; Ross M; Shpall EJ; Hussein A; Rizzieri D; Marks LB; Gilbert C; Affronti ML; Moore S; McDonald C; Petros WP; Peters WP
Biol Blood Marrow Transplant; 2006 Feb; 12(2):195-203. PubMed ID: 16443517
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up.
Ito Y; Mukaiyama T; Ogawa M; Mizunuma N; Takahashi S; Aiba K; Horikoshi N
Cancer Chemother Pharmacol; 1999; 43(1):8-12. PubMed ID: 9923535
[TBL] [Abstract][Full Text] [Related]
9. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.
Farquhar C; Marjoribanks J; Basser R; Hetrick S; Lethaby A
Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003142. PubMed ID: 16034887
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation for metastatic breast cancer.
Saez RA; Selby GB; Slease RB; Epstein RB; Mandanas RA; Confer DL
J Okla State Med Assoc; 1994 Sep; 87(9):405-10. PubMed ID: 7996314
[TBL] [Abstract][Full Text] [Related]
11. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
Laughlin MJ; McGaughey DS; Crews JR; Chao NJ; Rizzieri D; Ross M; Gockerman J; Cirrincione C; Berry D; Mills L; Defusco P; LeGrand S; Peters WP; Vredenburgh JJ
J Clin Oncol; 1998 Mar; 16(3):1008-12. PubMed ID: 9508184
[TBL] [Abstract][Full Text] [Related]
12. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.
Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S
Breast J; 2006; 12(6):531-5. PubMed ID: 17238982
[TBL] [Abstract][Full Text] [Related]
13. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.
Farquhar C; Basser R; Hetrick S; Lethaby A; Marjoribanks J
Cochrane Database Syst Rev; 2003; (1):CD003142. PubMed ID: 12535458
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Ayash LJ; Elias A; Wheeler C; Tepler I; Schwartz G; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(4):507-11. PubMed ID: 7916250
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
[TBL] [Abstract][Full Text] [Related]
16. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
17. Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.
Lotz JP; Bouleuc C; André T; Touboul E; Macovei C; Hannoun L; Lefranc JP; Houry S; Uzan S; Izrael V
Cancer; 1996 Jun; 77(12):2550-9. PubMed ID: 8640705
[TBL] [Abstract][Full Text] [Related]
18. [Autologous hematopoietic stem cell transplantation for the treatment of breast cancer].
Mukaiyama T; Okamoto R; Sasaki T
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1731-40. PubMed ID: 7574803
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
Brockstein BE; Williams SF
Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry.
Ladenstein R; Pearce R; Hartmann O; Patte C; Goldstone T; Philip T
Blood; 1997 Oct; 90(8):2921-30. PubMed ID: 9376572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
